Neisseria meningitidis, Serogroup B
"Neisseria meningitidis, Serogroup B" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Strains of Neisseria meningitidis which are the most common ones causing infections or disease in infants. Serogroup B strains are isolated most frequently in sporadic cases, and are less common in outbreaks and epidemics.
| Descriptor ID |
D038541
|
| MeSH Number(s) |
B03.440.400.425.550.550.641.710 B03.660.075.525.520.500.710
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neisseria meningitidis, Serogroup B".
Below are MeSH descriptors whose meaning is more specific than "Neisseria meningitidis, Serogroup B".
This graph shows the total number of publications written about "Neisseria meningitidis, Serogroup B" by people in this website by year, and whether "Neisseria meningitidis, Serogroup B" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neisseria meningitidis, Serogroup B" by people in Profiles.
-
Increased Risk of MenB Infection in College Students: Time to Reconsider Vaccine Recommendations? Pediatrics. 2019 01; 143(1).
-
Meningococcal Serogroup B Vaccine Immunogenicity in High-Risk Groups: What Are the Implications? Pediatrics. 2018 09; 142(3).
-
Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016. Emerg Infect Dis. 2017 05; 23(5):867-869.
-
Recommendations for Serogroup B Meningococcal Vaccine for Persons 10 Years and Older. Pediatrics. 2016 09; 138(3).
-
Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccine. J Infect Dis. 2007 May 15; 195(10):1472-9.
-
The future of meningococcal vaccines. Pediatr Infect Dis J. 2005 Feb; 24(2):175-6.